Current clinical rhinosinusitis management needs an upgrade
Rhinosinusitis(RS) affects 1 in 7 adults and results in substantial negative effects in terms of reduced productivity, quality of life and wasted healthcare costs. RS is also a very common pediatric issue that leads to over-prescription of antibiotic, which may be doing more harm than good in the longer-term public health. Recently, a number of expert panels have released guidelines for better management of rhinosinusitis in children and adults, and they all recognized the lack of simple and accurate office-based testing methods.
Potential new tool for detecting and monitoring rhinosinusitis
Praxis BioSciences, in collaboration with University of California researchers, have developed SinusCam™ a simple imaging system that can probe the insides of the maxillary sinuses in a matter of a few seconds. The system utilizes the similar technologies similar to the night time security camera - near-infrared light LEDs and digital cameras. Because it relies on harmless light, it can be used frequently to test on patients, which can be particularly useful for children as the CTs can expose them to unnecessary harmful x-ray radiation.
Current status of the SinusCam technology
The SinusCam has not yet been approved for clinical use by the FDA except for investigational studies with appropriate approval by an internal review board. So far, the technology has been tested in adult sinusitis patients in a clinical study at University of California Irvine. Study results indicate that SinusCam may become an essential tool for our primary care physicians in managing rhinosinusitis in adults.
Seeking clinical partners and strategic partners
We are currently seeking clinical researchers who will participate in expanded clinical study to establish the SinusCam as the standard of care device for rhinosinusitis management.
For additional information
Please contact us